CDMO News
1Q Health Group Expands with Acquisition of German CRO VivaCell Biotechnology
1Q Health Group, a European CDMO, has acquired VivaCell Biotechnology, a contract research organisation based in Germany. The acquisition supports the group’s aim to become a leading provider of premium pharmaceuticals and food supplements across Europe. VivaCell brings more than two
9 April 2025